In a filing, Health Catalyst Inc revealed its General Counsel Landry Benjamin unloaded Company’s shares for reported $23891.0 on Jun 05 ’25. In the deal valued at $3.94 per share,6,057 shares were sold. As a result of this transaction, Landry Benjamin now holds 151,125 shares worth roughly $0.58 million.
Then, BENJAMIN LANDRY bought 6,057 shares, generating $23,925 in total proceeds.
Before that, Benjamin Landry bought 3,255 shares. Health Catalyst Inc shares valued at $11,831 were divested by the Officer at a price of $3.63 per share.
BTIG Research downgraded its Health Catalyst Inc [HCAT] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Evercore ISI’s analysts, who decreased its forecast for the stock in early April from “an Outperform” to “an In-line”. KeyBanc Capital Markets also remained covering HCAT and has increased its forecast on January 08, 2025 with a “an Overweight” recommendation from previously “Sector weight” rating. KeyBanc Capital Markets revised its rating on April 10, 2024. It rated HCAT as “a Sector weight” which previously was an “an Overweight”.
Price Performance Review of HCAT
On Tuesday, Health Catalyst Inc [NASDAQ:HCAT] saw its stock fall -1.80% to $3.81. Over the last five days, the stock has lost -7.97%. Health Catalyst Inc shares have fallen nearly -46.11% since the year began. Nevertheless, the stocks have fallen -39.72% over the past one year. While a 52-week high of $9.24 was reached on 01/06/25, a 52-week low of $3.49 was recorded on 05/29/25.
Levels Of Support And Resistance For HCAT Stock
The 24-hour chart illustrates a support level at 3.63, which if violated will result in even more drops to 3.46. On the upside, there is a resistance level at 3.97. A further resistance level may holdings at 4.14.
